Detalhe da pesquisa
1.
Whole-genome and transcriptome analysis enhances precision cancer treatment options.
Ann Oncol
; 33(9): 939-949, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691590
2.
Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study.
Dis Esophagus
; 31(12)2018 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29905764
3.
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.
Ann Oncol
; 28(12): 3092-3097, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950338
4.
Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer.
Ann Oncol
; 27(5): 801-6, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27022066
5.
Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer.
Curr Oncol
; 23(5): 329-333, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803597
6.
Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study.
Curr Oncol
; 23(6): e571-e575, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28050146
7.
A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer.
Cancer Chemother Pharmacol
; 78(3): 541-5, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27422303
8.
A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer.
Eur J Cancer
; 50(11): 1909-15, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24857345